Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Luhui Wang
Institution:
First Affiliated Hospital of Wenzhou Medical University
Observed institution:
First Affiliated Hospital of Wenzhou Medical University
ORCID:
0000-0002-0686-6417
Observed ORCID:
0000-0002-0686-6417
OpenAlex ID:
A5048380108
Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
·
Clinical Cancer Research
·
60
Supplementary Table S2 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
·
1
Data from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Data from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Figure S3 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Table S6 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Table S4 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Table S1 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Table S5 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Figure S2 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Figure S4 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Table S3 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Figure S1 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
PDF
Supplementary Table S4 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Show more works
View as search
Works count:
14
Citation count:
60
H-index:
1
I10-index:
1
Year
Topic
Type